Health and Fitness Health and Fitness
Wed, September 29, 2010
[ Wed, Sep 29th 2010 ] - Market Wire
Covidien plc gibt Ergebnisse des vierten Quartals am 9. November 2010 bekannt
[ Wed, Sep 29th 2010 ] - Market Wire
Covidien plc pr©sentera ses r©sultats du quatrime trimestre le 9 novembre 2010
[ Wed, Sep 29th 2010 ] - Market Wire
Quidel Announces FDA Clearance of Its QuickVue® RSV 10 Immunoassay Diagnostic Test
[ Wed, Sep 29th 2010 ] - Market Wire
Covidien plc Divulgar Resultados do Quarto Trimestre em 9 de Novembro de 2010
[ Wed, Sep 29th 2010 ] - Market Wire
Covidien plc presentar los resultados correspondi .. tes al cuarto trimestre el 9 de noviembre de 2010
[ Wed, Sep 29th 2010 ] - Market Wire
Covidien plc to Report Fourth-Quarter Results on November 9, 2010
[ Wed, Sep 29th 2010 ] - Market Wire
BD Diagnostics and Bruker Collaborate to Improve .. fication and Antimicrobial Susceptibility Testing
[ Wed, Sep 29th 2010 ] - Market Wire
Wellstar International, Inc. Announces the Result .. n of the Duke University Study Have Been Accepted
Tue, September 28, 2010
[ Tue, Sep 28th 2010 ] - Market Wire
Prospect Medical Holdings, Inc. Announces End of aGo-Shopa Period
[ Tue, Sep 28th 2010 ] - Market Wire
Medtronic Advances Research on Drug-Eluting Balloons for Coronary and Peripheral Artery Disease
[ Tue, Sep 28th 2010 ] - Market Wire
HealthSpring, Inc. Announces the Addition of John T. Fox to Its Board of Directors
[ Tue, Sep 28th 2010 ] - Market Wire
Medtronica?s Insertable Cardiac Monitor Documented Arrhythmias in Post-Heart Attack Patients
[ Tue, Sep 28th 2010 ] - Market Wire
Covidien far Apresentao na conferncia "Jefferies European Healthcare Conference"
[ Tue, Sep 28th 2010 ] - Market Wire
Aetna Becomes First Georgia Insurer to Cover Medically Fragile Children for aDream Housea?
[ Tue, Sep 28th 2010 ] - Market Wire
Nicusa Capital Calls for Leadership Changes at BioClinica
[ Tue, Sep 28th 2010 ] - Market Wire
Synergetics USA to Present at Craig-Hallum Capital Group 2010 Alpha Select Conference
[ Tue, Sep 28th 2010 ] - Market Wire
Covidien presenteert tijdens congres Jefferies European Healthcare
[ Tue, Sep 28th 2010 ] - Market Wire
CellCyte Genetics Corp. Announces the Appointment of Douglas Pat Cerretti, Ph.D. to President
[ Tue, Sep 28th 2010 ] - Market Wire
Biojector®2000 Utilized in a Human Clinical Trial of DNA-MVA HIV Vaccine
[ Tue, Sep 28th 2010 ] - Market Wire
XenoPort Announces Presentation of New Data for XP21279 at World Parkinson Congress
[ Tue, Sep 28th 2010 ] - Market Wire
Amedisys Receives Civil Investigative Demand from the U.S. Department of Justice
[ Tue, Sep 28th 2010 ] - Market Wire
Health Net, Inc. to Hold Conference Call and Webc .. st to Discuss Third Quarter 2010 Earnings Results
[ Tue, Sep 28th 2010 ] - Market Wire
St. Jude Medical Announces Principal Investigator .. r Aortic Valve Implantation (TAVI) Clinical Trial
[ Tue, Sep 28th 2010 ] - Market Wire
Rochea?s New RTCA Cardio Instrument for Label-Free Functional Cardiomyocyte Toxicity Testing
[ Tue, Sep 28th 2010 ] - Market Wire
International Stem Cell Corporation Announces Sig .. ation of the First Bank of Immune-Matched Human P
[ Tue, Sep 28th 2010 ] - Market Wire
ARIAD to Present at the Jefferies Global SpecPharma and European Healthcare Conference
[ Tue, Sep 28th 2010 ] - Market Wire
Unigene Expands Board of Directors; Elects Joel A. Tune as Director
[ Tue, Sep 28th 2010 ] - Market Wire
Oncolytics Biotech Inc. Announces Issuance of Key U.S. Patent
[ Tue, Sep 28th 2010 ] - Market Wire
Covidien unter den Referenten auf der Jefferies European Healthcare Conference
[ Tue, Sep 28th 2010 ] - Market Wire
Presentazione di Covidien alla Jefferies European Healthcare Conference

Presentazione di Covidien alla Jefferies European Healthcare Conference


Published on 2010-09-28 04:10:35 - Market Wire
  Print publication without navigation


MANSFIELD, Mass.--([ BUSINESS WIRE ])--Covidien (NYSE: COV), azienda leader a livello mondiale nella fornitura di prodotti sanitari, terr una presentazione alla Jefferies 2010 Global SpecPharma and European Healthcare Conference a Londra il 5 ottobre 2010. Coleman N. Lannum, Vicepresidente, Relazioni con gli investitori, parler della societ in una presentazione programmata per le ore 7:30 (ET).

Sar possibile accedere a un webcast audio live della presentazione sul sito web Relazioni con gli investitori di Covidien: [ http://investor.covidien.com ].

INFORMAZIONI SU COVIDIEN

Covidien un'azienda di prodotti sanitari leader a livello mondiale che crea soluzioni mediche innovative al fine di migliorare i risultati clinici del paziente e offre un valore aggiunto attraverso leadership ed eccellenza nel settore sanitario.

Il testo originale del presente annuncio, redatto nella lingua di partenza, la versione ufficiale che fa fede. Le traduzioni sono offerte unicamente per comodit del lettore e devono rinviare al testo in lingua originale, che l'unico giuridicamente valido.

Contributing Sources